Adeshara, Krishna
Gordin, Daniel
Antikainen, Anni A.
Harjutsalo, Valma
Sandholm, Niina
Lehto, Markku J.
Groop, Per-Henrik
,
Funding for this research was provided by:
University of Helsinki
Article History
Received: 2 April 2024
Accepted: 16 June 2024
First Online: 4 July 2024
Declarations
:
: P-H.G. has received investigator-initiated research grants from Eli Lilly and Roche, lecture fees from Astellas, Astra Zeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, Elo Water, Medscape, MSD, Mundipharma, Novartis, Novo Nordisk, PeerVoice, Sanofi and SCIARC. He is an advisory board member for AbbVie, Astellas, Bayer, Boehringer-Ingelheim, Eli Lilly, Janssen, Medscape, MSD, Mundipharma, Nestlé, Novartis, Novo Nordisk, and Sanofi. D..G. has received lecture or advisory meeting honorariums from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, GE Healthcare, Novo Nordisk, and, Ratiopharm. All other authors declared that they had no conflict of interest.